| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |